”Generally speaking, the organs in older men undergo varying degrees of atrophy, and only the prostate is growing.” Prostatic hyperplasia is the most common disease in older men in China, except for a very small number of congenital testicular deficiency and other conditions, most older men have varying degrees of prostate hypertrophy, “It can be said that the incidence of men over 60 years of age is 80%, the incidence of men over 70 years of age is 90%, and over 90 years of age can reach almost 100%. “ ”Nowadays, it is not new for young adult men in their 30s to come to the hospital to see prostate enlargement,” due to unscientific dietary structure and poor lifestyle habits, the early age of onset of the disease has become increasingly evident. In addition, the risk of hypertension, stroke and cardiovascular disease is also greatly increased. New technology to reduce the post-operative recurrence rate to 1% It is understood that the effect of traditional transurethral resection is not very satisfactory, often about one-third of the residual hyperplastic tissue after surgery, some even residual hyperplastic tissue more than half, and the recurrence rate remains high, according to statistics, the recurrence rate of five years after surgery can be more than 18%. Even for open surgery, which is relatively ideal, the recurrence rate after surgery is about 8%. The older the patient, the greater the risk of surgery. The “transurethral resection of the prostate” can significantly reduce the recurrence rate after surgery. The “transurethral resection of the prostate gland” uses an electron microscope to completely remove the enlarged prostate tissue like peeling an orange, which is significantly better than traditional surgery in terms of reduced surgical trauma, lesion removal, post-operative recovery status, and shorter hospital stay. In the past four years since the procedure was applied in the clinic, the recurrence rate is less than 1% from the follow-up observation of more than 2000 cases of surgery. The technique has been positively evaluated by academic authorities at home and abroad, and is regarded as a further establishment and continuation of the “gold standard” of prostate surgery treatment.